PharmaFlow is the brainchild of Hedley Rees and is the encapsulation of his 25+ years working in big pharma and biotech, building, managing and continuously improving pharmaceutical supply-chains.

Unrivalled in the sector, PharmaFlow offers a unique blend of professional and industry skills, knowledge and experience:

• Practiced supply-chain management at leading organisations such as Bayer, Vernalis, Vanguard Medica, British Biotech, OSI Pharmaceuticals and Johnson & Johnson.
• Full Corporate Membership of the Chartered Institute of Purchasing and Supply
• Executive MBA from Cranfield School of Management, a top European Business School
• Professionally qualified in the tools and techniques of organisation and methods improvement
• Lectured Unipart buyers in Strategic supply-chain Management as part of the CIPS Professional Stage examinations
• Presenter on supply-chain management topics at leading industry conferences

Here's what some of our collaborators have to say:

“Helped us identify and rectify a number of supply-chain risks that would otherwise have placed our product launch in jeopardy.”

Nick Heightman, ex Commercial Director, Vanguard Medica and ex Senior Marketing Director, SmithKline Beecham and Wellcome.

“It has been valuable to draw on specialist supply-chain experience to help support our clients’ needs”

David Cotterell, Managing Director, Apex Healthcare Consulting Limited

“ Hedley’s (PharmaFlow managing Director) case study on building, managing and perfecting fully outsourced manufacturing and distribution supply-chains was extremely well received by our delegation of senior pharmaceutical executives.”

Olga Eracleous, Summit Producer, ManuPharma 2005, Marcus Evans Summits

"The ever increasing cost, risk and complexity involved in developing new pharmaceuticals demands that appropriate, robust supply-chains are established from the earliest stages of the development process in order to speed the progress of compounds to market."

Dr Neil Murray, Director, Essential Science Ltd and ex senior director in marketing and chemical development at various major leading industry suppliers and sponsor companies.

“This type of professional supply-chain management, when applied in collaboration with scientific and technical experts, can help transform business performance.”

Dr Paul Madeley, Managing Director, Synth-Isis Ltd and ex senior executive in chemical development at leading UK and US Biotech companies.

"Effective supply-chain management reduces the risk of regulatory delays or failure and creates shareholder value."

Dr Val Tate, Chief Executive, BioValue Ltd and leading expert in bioscience stakeholder communications.